SmartLife - Addressing the Needs of People with Diabetes (PwD) Using Machine Learning
|
|
- Elizabeth Oliver
- 5 years ago
- Views:
Transcription
1 SmartLife - Addressing the Needs of People with Diabetes (PwD) Using Machine Learning Tina Woerner, Roche Alexander Buesser, IBM September, 19th
2 Roche is a Basel based, global pharmaceutical company 2
3 doing pioneering work in personalised healthcare across diagnostics and pharma CHF 10.4 billion R&D investment 30 R&D sites worldwide ** CHF 53.3 billion sales 26 manufacturing sites worldwide #1 R&D investor in healthcare* Among top 10 R&D investors across industries * Strategy & Global Innovation 1000, Winter 2017 **Pharmaceuticals and Diagnostics 3
4 Our Vision By 2025 we will help people with diabetes everywhere in the world think less about their daily diabetes routine so they can get true relief, day an night. 4
5 st Diabetes is the global epidemic of the 21 century IMAGE BY GSFC / CC BY 2.0 5
6 6
7 Prevalence worldwide 1 of 11 adults has diabetes SOURCE: IDF DIABETES ALTAS 8TH ED., INTERNATIONAL DIABETES FEDERATION,
8 Prevalence worldwide World 425 M 2017 SOURCE: IDF DIABETES ALTAS 8TH ED., INTERNATIONAL DIABETES FEDERATION,
9 Prevalence worldwide World World 425 M M 2045 SOURCE: IDF DIABETES ALTAS 8TH ED., INTERNATIONAL DIABETES FEDERATION,
10 Prevalence worldwide 16 % 35% 110% 84% 15 % 62% 156% SOURCE: IDF DIABETES ALTAS 8TH ED., INTERNATIONAL DIABETES FEDERATION,
11 The challenge living with diabetes
12 More than 50 Therapy Decisions per day, every day Take blood glucose test Estimate carbohydrate intake Calories burned Calculate insulin dose Apply short-acting insulin Apply long-acting insulin Document data in diary Add mealtime info to diary Add health events to diary
13 Living with Diabetes 24 hours 13
14 Living with Diabetes 365 days 14
15 For the rest of your life. 15
16 The biggest challenge Stay in range
17 Job to be done: Keep glucose levels in range Hyper Hypo 17
18 Job to be done: Keep glucose level in range Hyper in Range Hypo 18
19 Three main factors are known to influence the glucose level 19
20 but for reliable estimates many hundred signals need to be taken into consideration 20
21 There is no mono-causal relation in a complex dynamic system 21
22 At the center of it, a human being is required to pull the strings 22
23 How can technology help? 23
24 Technology in the shape of mobile devices take on particular spots 24
25 Technology in the shape of mobile devices take on particular spots 25
26 All data from mobile accessories are transferred to a phone but most of the time into different apps 26
27 Product Vision Your glucose level is low and it will cross the hypo treshold within the next 30 minutes. How about a glass of apple juice? 27
28 We focused on three analytics areas Pattern detection Glucose prediction Focuses on describing historical Based on historical meal information, glucose data Information helps physician adjust the therapy Patient receives feedback on frequent occuring patterns Therapy advice activity, insulin amount and many other features glucose values are predicted To make predictions we need a learning Translates the glucose prediction into advice Simulations are made based on the prediction algorithm to evaluate the algorithm that can formulate the effect of different insulin and carb relationship between the variables to amounts for a particular time span mimic the human metabolism Results are translated into advice 28
29 and collaborated across organizations through a centralized analytics pipeline Centralized variable repository used for analytics Variable Similar patient identification Sample Variable filter Personalized predictive modeling Therapy advice 29
30 As patients metabolisms are very different we identified subpopulations in a clinically meaningful way 30
31 For each subpopulation we applied supervised learning methods Iterate over Historical input data and mulitple more samples Historical output data f(x) Example input data Glucose predictor 31
32 Three points to consider when innovating at the interface of healthcare and AI Co-innovation.. bringing Understand your signal s together people with different distributions. Do they make skills. Industry expertise as a sense in a particular context? Look beyond model accuracy! key differentiator. 32
33 Doing now what patients need next 33
34 Tina Wörner International Product Manager Solution Development Roche Diabetes Care GmbH Phone: Alexander Büsser Lead Data Scientist IBM Global Business Services Phone:
GLOOKO DREAMED FOR ANDROID USER GUIDE
GLOOKO DREAMED FOR ANDROID USER GUIDE November 2018 IFU-0017 02 TABLE OF CONTENTS TABLE OF CONTENTS GENERAL INFORMATION... 2 Product Description... 2 Glooko Intended Use... 2 Dreamed Intended Use... 2
More informationSmartSensor telemed Home OGTT Kit
SmartSensor telemed Home OGTT Kit NFC & Cloud Enabled Screening for Diabetes James Jackson, CEO, Oxford Roy Kelly, Chairman, Port St Mary Having an OGTT Today Assesses how the body handles glucose Remember
More informationBetter connected for better decisions
Introducing the Accu-Chek Connect diabetes management system Better connected for better decisions Help your patients use the power of their mobile devices and the web to manage their diabetes How many
More informationDiabetes Management App. Instruction Manual
Diabetes Management App Instruction Manual Accu-Chek Connect Diabetes Management App Overview The Accu-Chek Connect diabetes management app (hereafter referred to as the app) is designed to help you: Transfer
More informationBlood glucose Meter Roche USA V6/ PMS 287 Proof Print Number 209 Advanced Owner s Booklet
This file may not print or view at 100%. Die lines and color breaks do not print. Roche USA 50841 V6/1 06434258002 Black Proof Print Number 209 06434258002-0512 Roche USA 50841 V6/2 06434258002 Cyan Proof
More informationPOPULATION TRACKER MIDS USER GUIDE
POPULATION TRACKER MIDS USER GUIDE December 2018 IFU-0003 14 TABLE OF CONTENTS TABLE OF CONTENTS... 1 Intended Use... 1 Warnings... 1 Contraindications... 1 Compatible Browsers... 2 Treatment Plan Templates
More informationPowering mhealth. IM Associates. October 2016
Powering mhealth IM Associates October 2016 Background Many of our customers are looking to increase knowledge about the patients, the patient flow, treatment decision, Many questions are dealing with
More informationChronic illness is a growing market for Novo Nordisk
Chronic illness is a growing market for Novo Nordisk Aslam Dalvi - Associate Portfolio Manager Denmark-based global healthcare company Novo Nordisk traces its origins to the first pioneers in insulin production
More informationLarge Scale Predictive Analytics for Chronic Illness using FuzzyLogix s In-Database Analytics Technology on Netezza
Large Scale Predictive Analytics for Chronic Illness using FuzzyLogix s In-Database Analytics Technology on Netezza Christopher Hane, Vijay Nori, Partha Sen, Bill Zanine Fuzzy Logix Contact: Cyrus Golkar,
More informationHigh HbA1c. Paediatric Diabetes Patient Information Leaflet
High HbA1c Paediatric Diabetes Patient Information Leaflet Introduction You have been given this leaflet as you have a high HbA1c level (above 80mmol/mol). This leaflet gives more information on what HbA1c
More informationIntegrated Approaches in Diabetes Care The 4 Ds Author: Jochen Maas, General Manager R&D Germany, Date: 24/05/2018. Unlocking Tomorrow s Cures
Author: Jochen Maas, General Manager R&D Germany, Date: 24/05/2018 Unlocking Tomorrow s Cures 1 Tempora mutantur et nos in illis Data Diagnosis Drug Device Die Bedeutung der 4 D's 2 Definitions Drug A
More informationBlood Glucose Monitoring System. Copyright 2016 Ascensia Diabetes Care Holdings AG diabetes.ascensia.com
Viewing test results in My Readings The CONTOUR DIABETES app captures all your blood glucose readings to create personalized patterns and trends, so you can see how your daily activities impact your results.
More informationSmartphone Apps for Diabetes Management
Smartphone Apps for Diabetes Management By David Kerr, MD; Charis Hoppe; and Ceara AxelrodMarch 2017 There s an app for pretty much everything these days reading magazines (Diabetes Forecast has its own!),
More informationDiabetes and Kidney Disease: Time to Act. Your Guide to Diabetes and Kidney Disease
Diabetes and Kidney Disease: Time to Act Your Guide to Diabetes and Kidney Disease Diabetes is fast becoming a world epidemic Diabetes is reaching epidemic proportions worldwide. Every year more people
More informationFRANKFURT SITE TOUR 2017
FRANKFURT SITE TOUR 2017 MEDIA INFORMATION FRANKFURT SITE TOUR 2017 CONTENTS FRANKFURT INSULIN CITY... 4 5 DIABETES BACKGROUNDER... 6 DIABETES STATISTICS... 7 DIABETES MEDICINES... 8 IMAGE BANK... 9 NOTES...
More informationPresented by: Nathan Crone, M.D. and Mackenzie Cervenka, M.D. November 19 th, Innovation via Smart Watch: Meet Johns Hopkins EpiWatch
Presented by: Nathan Crone, M.D. and Mackenzie Cervenka, M.D. November 19 th, 2015 Innovation via Smart Watch: Meet Johns Hopkins EpiWatch Overview Introduction to seizures and epilepsy Mobile applications
More information11. December 2017 Marianne Birkeland Kjær
1 11. December 2017 Marianne Birkeland Kjær Presentation title Date 2 Agenda My Background Novo Nordisk Overview PhD and PostDoc opportunities How to apply for regular positions Novo Nordisk standard recruitment
More informationIntroducing DIA-TEC CLOUDTM. Technology. Education. Community. Your NEW Strategy for Diabetes Cost Management from the Experts at DECM
Introducing DIA-TEC CLOUDTM Technology. Education. Community. Your NEW Strategy for Diabetes Cost Management from the Experts at DECM Technology. Education. Community. Diabetes happens in real time. Now,
More informationPeople with type 1 diabetes and Do It Yourself (DIY) technology solutions ABOUT THIS POSITION STATEMENT
Position Statement People with type 1 diabetes and Do It Yourself (DIY) technology solutions ABOUT THIS POSITION STATEMENT Diabetes Australia believes that people with diabetes should have choice and access
More informationGlobal Insulin Pump Market with Focus on United States: Industry Analysis & Outlook ( )
Industry Research by Koncept Analytics Global Insulin Pump Market with Focus on United States: Industry Analysis & Outlook ----------------------------------------- (2018-2022) January 2019 1 Executive
More informationInvestor Update. Basel, 10 May 2018
Investor Update Basel, 10 May 2018 Roche provides update on Phase III study of Tecentriq (atezolizumab) and Cotellic (cobimetinib) in people with heavily pre-treated locally advanced or metastatic colorectal
More informationMedia Release. Roche announces progress in biomarker science in cancer immunotherapy at the European Society for Medical Oncology Congress
Media Release Basel, 08 September 2017 Roche announces progress in biomarker science in cancer immunotherapy at the European Society for Medical Oncology Congress First data on new blood-based assay for
More informationRoche receives FDA clearance for the VENTANA MMR IHC Panel for patients diagnosed with colorectal cancer
Media Release Roche receives FDA clearance for the VENTANA MMR IHC Panel for patients diagnosed with colorectal cancer The VENTANA MMR IHC Panel 1 helps differentiate between sporadic colorectal cancer
More informationBeyond AI: Bringing Emotional Intelligence to the Digital
Beyond AI: Bringing Emotional Intelligence to the Digital World Emotions influence every aspect of our lives how we live, work and play to the decisions we make We are surrounded by hyper-connected devices,
More informationUsing Health Economics to Inform the Development of Medical Devices. Matthew Allsop MATCH / BITECIC
Using Health Economics to Inform the Development of Medical Devices Matthew Allsop MATCH / BITECIC Overview Background to MATCH Overview of health economics in product development Concepts relating to
More informationData collection, summarizing data (organization and analysis of data) The drawing of inferences about a population from a sample taken from
1 Nature of Statistics The Study of statistics involves; Data collection, summarizing data (organization and analysis of data) and interpretation of data. The drawing of inferences about a population from
More informationTHE BENEFITS OF WORKING WITH FIBERSOL
THE BENEFITS OF WORKING WITH FIBERSOL WHY FIBER? Dietary fiber intake is recognized by professional and governmental authorities to be an important part of a healthful diet. As a result, dietary fiber
More informationThe Power and Promise of Digital Health
The Power and Promise of Digital Health Laurel Pickering, MPH EVP, Enterprise Solutions Welldoc, Inc. 2018 WellDoc, Inc. Intellectual Property. All rights reserved Agenda Problem are we trying to solve
More informationPOPULATION TRACKER - DREAMED USER GUIDE
POPULATION TRACKER - DREAMED USER GUIDE November 2018 IFU-0011 05 TABLE OF CONTENTS TABLE OF CONTENTS GENERAL INFORMATION... 1 Product Description... 1 Glooko Intended Use... 1 DreaMed Intended Use...
More informationInvestor Update. Basel, 23 April 2018
Investor Update Basel, 23 April 2018 New OCREVUS (ocrelizumab) data at AAN demonstrate significant reductions in disease activity and disability progression in relapsing multiple sclerosis Four years of
More informationPredictive Analytics and machine learning in clinical decision systems: simplified medical management decision making for health practitioners
Predictive Analytics and machine learning in clinical decision systems: simplified medical management decision making for health practitioners Mohamed Yassine, MD Vice President, Head of US Medical Affairs
More informationEU5 Bariatric Surgery Procedures Outlook to 2020
EU5 Bariatric Surgery Procedures Outlook to 2020 Reference Code: GDMECR0089PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...
More informationOWC PHARMACEUTICALS RESEARCH OTCQB:OWCP
OWC PHARMACEUTICALS RESEARCH OTCQB:OWCP Disclaimer This document details business information of OWC Pharmaceuticals Research Corp and/or our wholly-owned Israeli subsidiary, One World Cannabis Ltd. (collectively,
More informationitracker Word Count: 1453 Apper Contribution: 352 ECE Creative Applications for Mobile Devices For: Professor Jonathan Rose April 12, 2013
itracker Word Count: 1453 Apper Contribution: 352 ECE 1778 - Creative Applications for Mobile Devices For: Professor Jonathan Rose April 12, 2013 By: Baieruss Trinos (990072292) Babak Basseri (996441845)
More informationBig Data & Predictive Analytics Case Studies: Applying data science to human data Big-Data.AI Summit
Big Data & Predictive Analytics Case Studies: Applying data science to human data 1.03.2018 Big-Data.AI Summit Dr. Arnim Jost, Commercial Director Technology Copyright 2017 IQVIA. All rights reserved.
More informationVEGF Trap-Eye: New Data Confirm Successes in the Treatment of Age-related Macular Degeneration
Investor News Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Final Phase 2 Results Presented at Retina Society Meeting VEGF Trap-Eye: New Data Confirm Successes in the Treatment
More informationPatrick J. Sullivan, President & CEO March 7, 2016 Raymond James 37 th Annual Institutional Conference
Patrick J. Sullivan, President & CEO March 7, 2016 Raymond James 37 th Annual Institutional Conference Forward Looking Statement This presentation may contain forward-looking statements concerning Insulet's
More informationProgram Priorities 2018
Program Priorities 2018 Blank Page 2 CONTENTS: About CPRIT Program Priorities Project...Page 5 Process to Develop Program Priorities...Page 6 Scope of Program Priorities Project...Page 6 CPRIT s Long-Term
More informationPatrick J. Sullivan Chief Executive Officer. January 9, 2018 Investor Presentation
Patrick J. Sullivan Chief Executive Officer January 9, 2018 Investor Presentation Forward Looking Statement This presentation may contain forward-looking statements concerning Insulet's expectations, anticipations,
More informationBRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020
BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook Reference Code: GDMECR0130PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...
More informationData will be submitted to health authorities globally, including the US Food and Drug Administration (FDA) and European Medicines Agency (EMA)
Investor Update Basel, 20 November 2017 Phase III IMpower150 study showed Roche s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus chemotherapy significantly reduced the risk of disease worsening
More informationA FUTURE IN HEALTHCARE
A FUTURE IN HEALTHCARE Technology and Health Christian Caicedo MD, MBA, CPE, FACHE Vice President of Operations and Medical Director, West Shore Hospital PinnacleHealth System MOBILIZING HEALTH TECHNOLOGY
More informationStaying safe on an insulin pump
Staying safe on an insulin pump Exceptional healthcare, personally delivered Insulin pump therapy is a safe and effective way of treating diabetes. However due to the way the insulin is delivered, problems
More informationworry free diabetes care Ian Holmes [Manager], Tang Zhang [Designer], Albert Chen (hselin) [Documentation]
worry free diabetes care Ian Holmes [Manager], Tang Zhang [Designer], Albert Chen (hselin) [Documentation] Project Home Page http://stanford.edu/class/cs147/projects/information/ola/index.html App installation
More informationDouble Your Weight Loss By Using A Journal
Double Your Weight Loss By Using A Journal Agenda Why Journal? MyFitnessPal.com Introduction Finding the Site & Signing Up Navigating the Site Tracking Foods & Exercise Printing Information FAQs Why Journal?
More informationRoche announces FDA grants Venclexta(venetoclax) accelerated approval for people with hard-to-treat type of chronic lymphocytic leukemia
Media Release Basel, 12 April 2016 Roche announces FDA grants Venclexta(venetoclax) accelerated approval for people with hard-to-treat type of chronic lymphocytic leukemia Venclexta is designed to help
More informationOverview of Session 3 Taking Control of Your Diabetes (2)
Overview of Session 3 Taking Control of Your Diabetes (2) Objectives of session 3 Objectives for this session are that participants will: Understand what a hypo & hyper are and how to treat these Know
More informationWhat needs to happen in England
What needs to happen in England We ve heard from over 9,000 people across the UK about what it is like to live with diabetes and their hopes and fears for the future. Over 6,000 of them live in England;
More informationDIABETES - FACT SHEET
DIABETES - FACT SHEET What is diabetes? Diabetes mellitus, often shortened to diabetes, is a chronic condition that affects the body's ability to control blood sugar level and use energy from food. In
More informationWHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES?
Christian In better control with his pump since 2012 WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES? Many people with Type 1 diabetes worry about potential long-term
More informationLose It! Weight Loss App Competative Analysis Report
Lose It! Weight Loss App Competative Analysis Report By Manuel Ryan Espinsa Manuel Ryan Espinosa 3-4-2018 Competative Analysis IN4MATX 283 LEC A TABLE OF CONTENTS INTRODUCTION & GOALS DIRECT COMPETITORS
More informationMedia Release. Basel, 26 March 2018
Media Release Basel, 26 March 2018 Phase III IMpower150 study showed Roche s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus carboplatin and paclitaxel helped people with advanced lung cancer live
More informationAccelerated approval of Perjeta for neoadjuvant use also converted to full approval
Media Release Basel, 21 December 2017 FDA approves Roche s Perjeta (pertuzumab) for adjuvant treatment of specific type of early breast cancer Accelerated approval of Perjeta for neoadjuvant use also converted
More informationCALIPSO Project. an innovative approach to insulin therapy management
CALIPSO Project an innovative approach to insulin therapy management Preface Our project Preliminary business plan Project Team Calipso Project 2015 Why it should be so hard for diabetics to manage their
More informationTo ensure all education services at Mount Scopus Memorial College support students with diabetes.
Policy Document No: Category: Topic: ELC30 Early Learning Diabetes Policy Date of Issue: March 2012 Date last reviewed February 2016 Considerations Philosophy: Provide a safe and healthy environment for
More informationSo, My FitBit is Clinical Trial Grade Right? Keith Wenzel Senior Director, Solution Incubator PAREXEL International
So, My FitBit is Clinical Trial Grade Right? Keith Wenzel Senior Director, Solution Incubator PAREXEL International 1 Disclaimer The views and opinions expressed in the following PowerPoint slides are
More informationEssential advice for people with diabetes from Accu-Chek Alcohol
Essential advice for people with diabetes from Accu-Chek Alcohol and diabetes The impact of alcohol on blood glucose If I have diabetes does that mean I can t have a drink? Enjoying the occasional drink
More informationBordeaux Integrated Oncology Research (BRIO) Part of the French National Cancer Institute (INCa) Integrated Research Sites Network (SIRICs)
Bordeaux Integrated Oncology Research (BRIO) Part of the French National Cancer Institute (INCa) Integrated Research Sites Network (SIRICs) 1 Labellised between 2011 & 2012 8 Integrated Cancer Research
More informationEli Lilly Canada. Providing Answers That Matter. CPM talks to Gaetano Crupi, President and General Manager, Eli Lilly Canada.
Providing Answers That Matter CPM talks to Gaetano Crupi, President and General Manager, Eli Lilly Canada. CPM: Please describe Lilly s structure, both in Canada and abroad. Gaetano Crupi President and
More informationExpanding the boundaries of nutrition Luis Cantarell
Expanding the boundaries of nutrition Luis Cantarell Nestlé Investor Seminar 30 September 2013 Disclaimer This presentation contains forward looking statements which reflect Management s current views
More informationMedia Release. FDA grants Priority Review for Roche s Perjeta (pertuzumab) for adjuvant treatment of HER2-positive early breast cancer
Media Release Basel, 29 September 2017 FDA grants Priority Review for Roche s Perjeta (pertuzumab) for adjuvant treatment of HER2-positive early breast cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced
More informationFuture of Diabetes Research in Europe JDRF Perspective
Future of Diabetes Research in Europe JDRF Perspective IMI-JDRF Diabetes Patient Meeting 20 May 2014 Brussels, Belgium Olivier ARNAUD, Pharm D JDRF European Research Director oarnaud@jdrf.org Future of
More informationThe Sweet & Bitter Facts
The Sweet & Bitter Facts We previously introduced Ricebowl Asia s readers on importance of Carbohydrates in our diet its functions to human bodies. Since we were previously discussing about good ol Carbs,
More informationSmartSensor Home OGTT Kit For Detection Of Diabetes
SmartSensor Home OGTT Kit For Detection Of Diabetes Background to Diabetes Global diabetes epidemic 50% of type 2 undiagnosed; 183m people Prediabetes affects over 350m people 18% of pregnancies affected
More informationAsia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020
Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Reference Code: GDMECR0107PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3
More informationRadiation Oncology. The conf ident path to treatment Philips Radiation Oncology Solutions
Radiation Oncology The conf ident path to treatment Philips Radiation Oncology Solutions The confident path to treatment Philips Radiation Oncology Solutions Imaging Image registration Contouring Treatment
More informationInvestor Update. Downloads. Services PDF. Basel, 15 May 2018
Investor Update Basel, 15 May 2018 FDA approves subcutaneous formulation of Actemra for use in active polyarticular juvenile idiopathic arthritis (pjia), a rare form of juvenile arthritis Roche (SIX: RO,
More informationCollaborating to Develop Digital Biomarkers with Passive Data Collection
Collaborating to Develop Digital Biomarkers with Passive Data Collection Iain Simpson IXICO June 2018 1 Setting of Data Collection Market evolution: biosensors and digital biomarkers Clinic Home Digital
More informationAbout The Report. imarc. Key Questions Answered in this Report:
About IMARC For more than 5 years, the International Market Analysis Research and Consulting Group has been a leading advisor on management strategy and market research worldwide. We partner with clients
More informationJOSLIN INGENUITY DIGITAL IMPACT INNOVATION BIG DATA CAPACITY TRANSLATIONAL AGILITY COLLABORATION COLLABORATION JENESIS
CONFIDENCE OUTCOMES ALLIANCES CATALYST COLLABORATION AGILITY JOSLIN INGENUITY CAPACITY IMPACT INNOVATION GLOBAL ACCELERATION COLLABORATION JENESIS BIG DATA TRANSLATIONAL DIGITAL Contents 2 Partnering for
More informationDexcom: CGM technology, IoT connectivity, and the drive to insight delivery in diabetes care
Data @ Dexcom: CGM technology, IoT connectivity, and the drive to insight delivery in diabetes care Nate Heintzman, PhD Sr. Manager, Data Partnerships 20161130 MILLIONS 700 Diabetes is a global crisis
More informationAsia-Pacific Bariatric Surgery Devices Market Outlook to 2020
Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List
More informationThis is a licensed product of Ken Research and should not be copied
1 TABLE OF CONTENTS 1. The US Diabetes Care Devices Market Introduction 1.1. What is Diabetes and it s Types? 2. The US Diabetes Care Devices Market Size, 2007-2013 3. The US Diabetes Care Devices Market
More informationC o n n e c t e d I n s u l i n D e l i v e r y S y s t e m
Technology Innovation Alert C o n n e c t e d I n s u l i n D e l i v e r y S y s t e m 6 July 12 July, 2018 1 4 0 0 Start ups Companies Universities Individuals Interesting Innovation Compliance with
More informationType 1 Diabetes (T1D) Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research
Type 1 Diabetes (T1D) Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research "Type 1 diabetes market size was valued at USD 25.52 billion in 2016 and is expected to exhibit rewarding
More informationmysugr App Manual 1 Getting started 1.1 Key features Quick and easy data entry. Smart search. Neat and clear graphs.
mysugr App Manual Version: 3.42_iOS - 2018-01-29 1 Getting started 1.1 Key features Quick and easy data entry. Smart search. Neat and clear graphs. Handy photo function (multiple pics per entry). Exciting
More informationFirst phase III data on Roche s TECENTRIQ (atezolizumab) to feature at the 2016 European Society for Medical Oncology (ESMO) Congress
Media Release Basel, 03 October 2016 First phase III data on Roche s TECENTRIQ (atezolizumab) to feature at the 2016 European Society for Medical Oncology (ESMO) Congress Superiority results from the phase
More informationBlood testing at your finger tips. Know Now. No waiting. A pocket laboratory for the 21 st century
Blood testing at your finger tips. Know Now. No waiting. A pocket laboratory for the 21 st century 1 Blood testing is a huge global high growth market Driving Market Growth: $51.8 billion $60.6 billion
More informationEssential advice for people with diabetes from Accu-Chek. Get the low-down on hypos
Essential advice for people with diabetes from Accu-Chek Get the low-down on hypos The low-down on hypos If you have diabetes, a hypo is one of those things you have to deal with from time to time. FIRST
More informationUsing Predictive Analytics to Save Lives
March 2018 1 Using Predictive Analytics to Save Lives Presented by Sybil Klaus MD MPH, MITRE, and James Fackler MD, Johns Hopkins University School of Medicine Approved for Public Release; Distribution
More informationNow you know. InPen MOBILE APP. Healthcare Provider INSTRUCTIONS FOR USE. CompanionMedical.com Companion Medical, Inc.
InPen MOBILE APP Healthcare Provider INSTRUCTIONS FOR USE 2017 Companion Medical, Inc. LBL-00235-AC TABLE OF CONTENTS Introduction...3 InPen Mobile App...3 Intended Use...3 Indications for Use...3 Contraindications...3
More informationPharmaceutical market
Pharmaceutical market I s P h a r m a a s i m p o r t a n t a s i t s e m p l o y e e s t h i n k? Our lives are getting longer In Europe, over the last 65 years, we have obeserved a significant increase
More informationMichael L. Levitz Chief Financial Officer. November 15, 2017 Investor Presentation
Michael L. Levitz Chief Financial Officer November 15, 2017 Investor Presentation Forward Looking Statement This presentation may contain forward-looking statements concerning Insulet's expectations, anticipations,
More informationLive life, less complicated. InPen MOBILE APP. Healthcare Provider INSTRUCTIONS FOR USE. CompanionMedical.com
InPen MOBILE APP Healthcare Provider INSTRUCTIONS FOR USE TABLE OF CONTENTS Introduction...3 InPen Mobile App...3 Intended Use...3 Indications for Use...3 Contraindications...3 Start Orders...4 General
More informationEMPOWER Support of patient empowerment by an intelligent self-management pathway for patients
EMPOWER Support of patient empowerment by an intelligent self-management pathway for patients Manuela Plößnig, Salzburg Research manuela.ploessnig@salzburgresearch.at http://www.empower-fp7.eu The research
More informationNutrition and Healthy Eating Games ABOUT SIYANA
Nutrition and Healthy Eating Games Kids as young as two are using technology as a way of learning through play, apps like Clever Kid Yum Yum is aimed for 2-4 year olds and aims to teach them about the
More informationBigMedilytics Big Data for Medical Analytics
01010010010100100100010101001 010100010100010 01010 10010010010001010 01010010010010010010010 0100100100010001001001001 BigMedilytics Big Data for Medical Analytics 001010010100101 1010010010001001001
More informationComputational Neuroscience. Instructor: Odelia Schwartz
Computational Neuroscience 2017 1 Instructor: Odelia Schwartz From the NIH web site: Committee report: Brain 2025: A Scientific Vision (from 2014) #1. Discovering diversity: Identify and provide experimental
More informationmysugr App Manual 1 Getting started 1.1 Key features Quick and easy data entry. Smart search. Neat and clear graphs.
mysugr App Manual Version: 3.32_iOS - 11/04/2017 1 Getting started 1.1 Key features Quick and easy data entry. Smart search. Neat and clear graphs. Handy photo function (multiple pics per entry). Exciting
More informationInnovation from the Foundation Sonya Dumanis, PhD
Highlights in Research and Innovation from the Foundation Sonya Dumanis, PhD Senior Director of Innovation EPILEPSY FOUNDATION Our Mission: To lead the fight to overcome the challenges of living with epilepsy
More informationInnovator Case Studies: Oncology Networks
Innovator Case Studies: Oncology Networks J. Ike Nicoll Chief Executive Officer Cancer Clinics of Excellence Alan Armer, Ph.D. Vice President, Research & Development Catholic Health Initiatives Cancer
More informationLogbook Manual. 1 Getting started. 1.1 Key features. Quick and easy data entry. Smart search. Neat and clear graphs.
Logbook Manual Version: 3.29_Android - 23/02/2017 1 Getting started 1.1 Key features Quick and easy data entry. Smart search. Neat and clear graphs. Handy photo function (multiple pics per entry). Exciting
More informationDiabetes. What is diabetes?
Diabetes 966 860 258 www.medcarespain.com doctors@medcarespain.com The incidence of diabetes has reached epidemic proportions. About 350 million people worldwide have diabetes, and according to the World
More informationFDA grants Roche s Alecensa Priority Review for initial treatment of people with ALK-positive lung cancer
Investor Update Basel, 3 August 2017 FDA grants Roche s Alecensa Priority Review for initial treatment of people with ALK-positive lung cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the
More informationADA 2018 JUN 25, 2018 ORLANDO, FLORIDA
ADA 2018 JUN 25, 2018 ORLANDO, FLORIDA FORWARD LOOKING STATEMENTS This presentation contains forward-looking statements. They are based on current assumptions and expectations that involve uncertainties
More informationEssential advice for people with diabetes from Accu-Chek Alcohol
Essential advice for people with diabetes from Accu-Chek Alcohol and diabetes The impact of alcohol on blood glucose If I have diabetes does that mean I can t have a drink? Enjoying the occasional drink
More informationclassic licensing program inflamaging
classic licensing program inflamaging physician network inflamaging physician network About Us Healthcare, The Way It's Meant To Be It is no secret that physicians incomes have been falling over the past
More informationMedia Release. Basel, 20 March 2018
Media Release Basel, 20 March 2018 Phase III IMpower131 study showed Roche s TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death in the
More informationI can tell you how much insulin. to give and when
Our Journey with Diabetes Si usted desea esta información en español, por favor pídasela a su enfermero o doctor. I can tell you how much insulin How much insulin does my child need? Your child needs enough
More information